Authors

• Linda E. Greenbaum
• Michael K. Badman
• Miljen Martić (ORCID: https://orcid.org/0000-0002-0166-5421)
• Nikolai V. Naoumov (ORCID: https://orcid.org/0009-0009-3091-4990)
• Phillip J. Koo (ORCID: https://orcid.org/0000-0002-5375-3773)
• Julia Zack
• Heng Zhou (ORCID: https://orcid.org/0000-0002-1457-4166)
• Brijesh Yadav (ORCID: https://orcid.org/0000-0002-6447-5799)
• H. Weiss (ORCID: https://orcid.org/0000-0003-0280-4814)
• Chinweike Ukomadu (ORCID: https://orcid.org/0000-0002-7433-0083)
• Eric Lawitz (ORCID: https://orcid.org/0000-0002-4234-224X)
• Clive Drakeford
• Robert Schmouder (ORCID: https://orcid.org/0000-0001-9896-7305)
• Juan P. Frías (ORCID: https://orcid.org/0000-0001-9486-1255)
• Yiming Zhang (ORCID: https://orcid.org/0000-0002-8933-1871)

Institutions

• Novartis (Switzerland) (CH)
• The University of Texas at San Antonio Health Science Center (US)
• Novartis (United States) (US)
• Velocity Clinical Research (United States) (US)
• Texas Liver Institute (US)
• Novartis (Ireland) (IE)

Publication Details

Journal

Alimentary Pharmacology & Therapeutics

Published

2025-11-26

DOI

https://doi.org/10.1111/apt.70475

Citations

2

Primary Topic

Liver Disease Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

2.71

Funders

• Novartis Pharma